The 7 analysts offering 12-month price forecasts for Kala Pharmaceuticals Inc have a median target of 19.00, with a high estimate of 39.00 and a low estimate of 15.00. The median estimate represents a +113.00% increase from the last price of 8.92.
The current consensus among 7 polled investment analysts is to Buy stock in Kala Pharmaceuticals Inc. This rating has held steady since July, when it was unchanged from a Buy rating.Move your mouse over past months for detail
Earnings and Sales Forecasts
Earnings per Share -$0.39
Reporting Date Nov 04
Earnings per Share
Move your mouse over a quarter or year to see how estimates have changed over time.